Page last updated: 2024-10-22

amitriptyline and Ebola Hemorrhagic Fever

amitriptyline has been researched along with Ebola Hemorrhagic Fever in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mohammed, A1
Sheikh, TL1
Gidado, S1
Abdus-Salam, IA1
Adeyemi, J1
Olayinka, A1
Ohuabunwo, C1
Victor, OO1
Nguku, P1
Rasheed, EA1
Doherty, F1
Waziri, N1
Shuaib, F1
Joseph, BO1
Bomai, IM1
Oyemakinde, A1

Other Studies

1 other study available for amitriptyline and Ebola Hemorrhagic Fever

ArticleYear
Psychiatric treatment of a health care worker after infection with Ebola virus in Lagos, Nigeria.
    The American journal of psychiatry, 2015, Mar-01, Volume: 172, Issue:3

    Topics: Adjustment Disorders; Amitriptyline; Antidepressive Agents, Tricyclic; Behavioral Symptoms; Brain Di

2015